BlackRock
RDHL

BlackRock’s Redhill Biopharma RDHL Stock Holding History

BlackRock’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-339
Closed -$171K – 5832
2022
Q3 		$171K Sell
339
-18
-5% -$15.7K ﹤0.01% 5013
2022
Q2 		$311K Hold
357
– – ﹤0.01% 4913
2022
Q1 		$901K Buy
357
+56
+19% +$133K ﹤0.01% 4699
2021
Q4 		$778K Sell
301
-11
-4% -$44K ﹤0.01% 4741
2021
Q3 		$1.43M Buy
312
+24
+8% +$163K ﹤0.01% 4457
2021
Q2 		$1.98M Sell
288
-68
-19% -$469K ﹤0.01% 4269
2021
Q1 		$2.6M Buy
356
+23
+7% +$193K ﹤0.01% 4208
2020
Q4 		$2.69M Buy
+333
New +$2.99M ﹤0.01% 3943

Other funds holding RDHL

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BlackRock's RDHL Position: Q4 2022 in Review

BlackRock sold out of Redhill Biopharma (RDHL) in Q4 2022, closing a stake of 339 shares — an estimated $171K sold.

BlackRock first reported a position in RDHL in Q4 2020 and held it in 8 quarters. The position peaked at $2.69M in Q4 2020. 37 funds tracked by Wall St. Rank hold RDHL as of Q4 2022.

  • BlackRock reported no remaining Redhill Biopharma position as of Q4 2022 after selling out during the quarter.
  • BlackRock sold 339 Redhill Biopharma shares in Q4 2022, an estimated $171K.
  • BlackRock first reported a position in Redhill Biopharma in Q4 2020 and held it in 8 quarters.
  • BlackRock's Redhill Biopharma position peaked at $2.69M in Q4 2020.
  • 37 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.